Dr. Shimizu has over 35 years of corporate experience in ophthalmology. In 1992 his focus transitioned from research to product development. Rob has led cross-functional teams focused on product development of pharmaceuticals (including drug delivery), ocular devices and combination products. These activities developed treatments for diseases in both the anterior and posterior segments of the eye. Rob has led pharmaceutical development, device development, preclinical testing, clinical evaluation and regulatory activities addressing global markets.
Dr. Rob Shimizu brings over 35 years of corporate experience in ophthalmology ranging from research to development of pharmaceuticals, ocular devices, and combination products for diseases in both the anterior and posterior segments of the eye. Rob has successfully led multinational—interdisciplinary teams through regulatory activities leading to approvals in North America, the EU, and Asia.